Filing Details
- Accession Number:
- 0001209191-23-058376
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-12 18:49:28
- Reporting Period:
- 2023-12-08
- Accepted Time:
- 2023-12-12 18:49:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1111485 | Rxsight Inc. | RXST | Ophthalmic Goods (3851) | 943268801 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1874373 | Keith Robert Warner | C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-08 | 14,502 | $35.01 | 29,248 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2023-12-11 | 5,498 | $35.08 | 23,750 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 27,733 | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 24, 2023 by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 14,502 shares sold in the price range of $35.00 to $35.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.
- Represents the weighted average share price of an aggregate total of 5,498 shares sold in the price range of $35.00 to $35.20 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.